Distribution and Drug Sensitivity of Pathogenic Bacteria in Diabetic Foot Ulcer Patients With Necrotizing Fasciitis at a Diabetic Foot Center in China
Abstract Background: When a diabetic foot ulcer (DFU) is complicated by necrotizing fasciitis (DNF), this may increase the risk for amputation and mortality, making DNF treatment more complicated, and may eventually lead to amputation and mortality. DNF treatment must include the appropriate antibiotic intervention. However, studies on the distribution and drug sensitivity of pathogenic bacteria in DNF patients remain lacking. This study investigated the distribution and susceptibility of pathogenic bacteria in DNF patients, and provides empirical antibacterial guidance for the clinic.Methods: In a single diabetic foot center, the results from microbial cultures and drug susceptibility tests of patients with DNF from October 2013 to December 2020 were collected and analyzed.Results: A total of 101 DNF patients were included in this study, of whom 94 had positive culture test results. A total of 124 pathogens were cultured, including 76 Gram-positive bacterial strains, 42 Gram-negative bacterial strains, and six fungal strains. Polymicrobial infections accounted for 26.7% and monomicrobial infections accounted for 66.3%. Staphylococcus aureus was the most common bacterium isolated, followed by Enterococcus faecalis and Streptococcus agalactiae. Pseudomonas aeruginosa, Klebsiella pneumoniae, and Proteus mirabilis were the most common Gram-negative bacteria. Thirty-five strains of multi-drug resistant (MDR) bacteria were isolated, representing 28.2% of the total isolates. Gram-positive bacteria were more sensitive to levofloxacin, moxifloxacin, vancomycin, teicoplanin, tigecycline, and linezolid, while Gram-negative bacteria were more sensitive to amikacin, piperacillin/tazobactam, cefoperazone/sulbactam, ceftazidime, cefepime, imipenem, and meropenem. Conclusions: Gram-positive bacteria were the main bacteria isolated from DNF patients. The bacterial composition, the proportion of MDR bacteria among the pathogens, and high risk for amputation should be fully considered in the initial empirical medication, and broad-spectrum antibacterials are recommended.